Efficacy and safety of sitagliptin as a third therapeutic agent in the treatment of type 2 diabetes mellitus
2014
Abstract
Background: Information on sitagliptin as a third line agent in combination with other antidiabetic agents is still lacking. This study evaluated the safety and efficacy of sitagliptin as an add-on therapyin
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
20
References
0
Citations
NaN
KQI